Links between critical proteins drive the controllability of protein interaction networks S Wuchty, T Boltz, H Küçük‐McGinty Proteomics 17 (10), 1700056, 2017 | 25 | 2017 |
Promoter conservation in HDACs points to functional implications TA Boltz, S Khuri, S Wuchty BMC genomics 20, 1-12, 2019 | 12 | 2019 |
Gene expression imputation across multiple tissue types provides insight into the genetic architecture of frontotemporal dementia and its clinical subtypes LM Reus, B Pasaniuc, D Posthuma, T Boltz, R Ferrari, DG Hernandez, ... Biological psychiatry 89 (8), 825-835, 2021 | 10 | 2021 |
Powerful eQTL mapping through low-coverage RNA sequencing T Schwarz, T Boltz, K Hou, M Bot, C Duan, LO Loohuis, MP Boks, ... Human Genetics and Genomics Advances 3 (3), 2022 | 9 | 2022 |
Collective influencers in protein interaction networks TA Boltz, P Devkota, S Wuchty Scientific reports 9 (1), 3948, 2019 | 8 | 2019 |
Polygenic Risk Associations with Clinical Characteristics and Recurrence of Dupuytren Disease SA Riesmeijer, IM Nolte, LMO Loohuis, LM Reus, T Boltz, M Ng, D Furniss, ... Plastic and Reconstructive Surgery 153 (3), 573e-583e, 2024 | 2 | 2024 |
Genome‐wide Quantitative Trait Loci (QTL) Mapping of Metabolites in Human Cerebrospinal Fluid N Zeltser, R Elting, T Boltz, LO Loohuis, R Ophoff The FASEB Journal 34 (S1), 1-1, 2020 | 2 | 2020 |
Fibroblasts as an in vitro model of circadian genetic and genomic studies M Francia, M Bot, T Boltz, JF De La Hoz, M Boks, R Kahn, R Ophoff bioRxiv, 2023.05. 19.541494, 2023 | 1 | 2023 |
182. Transcriptional Profiling of Antidepressant Ketamine Treatment A Zavaliangos-Petropulu, T Boltz, L Zhan, N Al-Sharif, B Taraku, ... Biological Psychiatry 95 (10), S173-S174, 2024 | | 2024 |
Fibroblasts as an in vitro model of circadian genetic and genomic studies: A temporal analysis M Francia, M Bot, T Boltz, F Juan, M Boks, R Kahn, R Ophoff bioRxiv, 2024 | | 2024 |
HAND/PERIPHERAL NERVE SA Riesmeijer, IM Nolte, LMO Loohuis, LM Reus, T Boltz, M Ng, ... Plastic and Reconstructive Surgery, 2024 | | 2024 |
Cell-type deconvolution of bulk-blood RNA-seq reveals biological insights into neuropsychiatric disorders T Boltz, T Schwarz, M Bot, K Hou, C Caggiano, S Lapinska, C Duan, ... The American Journal of Human Genetics 111 (2), 323-337, 2024 | | 2024 |
Cerebrospinal fluid metabolome‐wide association study of Alzheimer’s disease provides insight into molecular pathways LM Reus, T Boltz, M Francia, M Bot, LO Loohuis, CE Teunissen, R Ophoff, ... Alzheimer's & Dementia 19, e078688, 2023 | | 2023 |
F104. Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid reveals insights into biological mechanisms. L Reus, T Boltz, M Francia, M Bot, N Ramesh, WM van der Flier, PJ Visser, ... European Neuropsychopharmacology 75, S275, 2023 | | 2023 |
W45. PREDICTION OF ALZHEIMER'S DISEASE BIOMARKERS USING GENOMICS AND CEREBROSPINAL FLUID METABOLOMICS M Francia, N Ramesh, T Boltz, L Reus, M Bot, WM van der Flier, PJ Visser, ... European Neuropsychopharmacology 75, S127-S128, 2023 | | 2023 |
W37. CHANGES IN PERIPHERAL GENE EXPRESSION FOLLOWING ANTIDEPRESSANT KETAMINE TREATMENT A Zavaliangos-Petropulu, T Boltz, N Al-Sharif, B Taraku, E Congdon, ... European Neuropsychopharmacology 75, S124, 2023 | | 2023 |
Fibroblasts as anin vitromodel of circadian genetic and genomic studies M Francia, M Bot, T Boltz, JF De La Hoz, M Boks, R Kahn, R Ophoff | | 2023 |
Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes LM Reus, T Boltz, M Francia, M Bot, N Ramesh, M Koromina, ... Biorxiv, 2023.09. 26.559021, 2023 | | 2023 |
Functional genomics study of neuropsychiatric disorders through integration of chromatin regulation, transcriptomics, and metabolomics TA Boltz University of California, Los Angeles, 2023 | | 2023 |
T71. FIBROBLASTS AS AN IN VITRO MODEL OF CIRCADIAN GENETIC AND GENOMIC STUDIES M Francia, M Bot, T Boltz, J De la Hoz, R Ophoff European Neuropsychopharmacology 63, e206-e207, 2022 | | 2022 |